AACR by the numbers

An AACR abstract preview by indications, targets and institutions

See Figure: Top indications

See Table: Novel cancer targets at AACR 2016

See Figure: Top institutions and companies

See Figure: Top targets


Novel cancer targets at AACR 2016
Breast cancer amplified sequence 1 (BCAS1)Non-small cell lung cancer (NSCLC)In vitro studies suggest knocking down BCAS1, a gene overexpressed in tumor tissues, could increase sensitivity of NSCLC cell lines to radiation.Dana-Farber Cancer Institute1650
Chromodomain helicase DNA binding protein 4 (CHD4)SarcomaProteomic and genetic screens , and mouse studies suggest silencing or

Read the full 744 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers